We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
-4.34%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$299M
AUM Growth
-$63.9M
Cap. Flow
-$54.5M
Cap. Flow %
-18.25%
Top 10 Hldgs %
28.29%
Holding
166
New
33
Increased
12
Reduced
17
Closed
48

Top Buys

Rank Stock Value
1
PEPLU
PepperLime Health Acquisition Corporation Unit
PEPLU
+$7.47M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$5.84M
3
DXCM icon
DexCom
DXCM
+$5.47M
4
KPTI icon
Karyopharm Therapeutics
KPTI
+$5.36M
5
IMGN
Immunogen Inc
IMGN
+$5.09M

Top Sells

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$8.71M
2
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
+$7.2M
3
IMTX icon
Immatics
IMTX
+$6.32M
4
NSTG
NanoString Technologies, Inc.
NSTG
+$6.19M
5
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$5.62M

Sector Composition

Rank Sector Weight
1 Healthcare 78.49%
2 Financials 7.32%
3 Industrials 1.2%
4 Technology 0.83%
5 Communication Services 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CINGW icon
101
Cingulate Inc Warrants
CINGW
$33.2K
$108K 0.04%
270,000
– –
MBTCR
102
DELISTED
Nocturne Acquisition Corporation Right
MBTCR
$105K 0.04%
500,000
– –
OBIO icon
103
Orchestra BioMed
OBIO
$254M
$99K 0.03%
10,000
– –
NXGLW icon
104
NexGel Inc Warrant
NXGLW
$88K 0.03%
225,000
– –
CALA
105
DELISTED
Calithera Biosciences, Inc
CALA
$82K 0.03%
+10,114
New +$103K
NLSPW
106
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$76K 0.03%
200,000
– –
LAAAW
107
DELISTED
Lakeshore Acquisition I Corp. Warrant
LAAAW
$53K 0.02%
150,000
– –
MOBXW icon
108
Mobix Labs Warrants
MOBXW
$30K 0.01%
150,000
– –
SRSAW
109
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
$27K 0.01%
75,000
– –
EUCRW
110
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$25K 0.01%
133,333
– –
TMPMW
111
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$24K 0.01%
84,666
– –
SRZNW icon
112
Surrozen Inc Warrant
SRZNW
$8.86K
$21K 0.01%
82,233
– –
OHAAW
113
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$20K 0.01%
+50,000
New +$22.5K
ADRT.WS
114
DELISTED
Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
ADRT.WS
$19K 0.01%
+112,500
New +$19.8K
GIWWW
115
DELISTED
GigInternational1, Inc. Warrant
GIWWW
$18K 0.01%
50,000
– –
AXH.WS
116
DELISTED
Industrial Human Capital, Inc. Warrants
AXH.WS
$18K 0.01%
100,000
– –
MITAW
117
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$10K ﹤0.01%
28,333
– –
PSQH.WS icon
118
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.73M
$5K ﹤0.01%
16,666
– –
ATEC icon
119
Alphatec Holdings
ATEC
$1.44B
– –
-255,000
Closed -$2.92M
AVDL
120
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-440,589
Closed -$3.56M
BBIO icon
121
CALL
BridgeBio Pharma
BBIO
$16.5B
– –
-54,300
Closed -$906K
CELC icon
122
Celcuity
CELC
$4.52B
– –
-145,000
Closed -$1.91M
CERS icon
123
Cerus
CERS
$474M
– –
-465,000
Closed -$3.17M
CING icon
124
Cingulate
CING
$71.9M
– –
-350
Closed -$232K
CNTB
125
Connect Biopharma Holdings
CNTB
$139M
– –
-175,000
Closed -$901K
3 4
5
6 7

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Altium Capital Management held 166 positions worth $299M, down 18% from $363M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Altium Capital Management withdrew a net $54.5M in Q1 2022, closing 48 positions and reducing 17 holdings. Its most notable exit was PepperLime Health Acquisition Corporation Class A Ordinary Share, an estimated $7.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 80% a quarter earlier, followed by Financials and Industrials.

Against the trend, Altium Capital Management opened a new position in PepperLime Health Acquisition Corporation Unit worth $7.23M.

  • Altium Capital Management's largest Q1 2022 buy was PepperLime Health Acquisition Corporation Unit: 735,000 shares worth $7.23M.
  • Altium Capital Management added most to NEVRO CORP. in Q1 2022, an estimated $2.52M increase.
  • Altium Capital Management's biggest Q1 2022 reduction was Lantheus, cutting an estimated $8.71M.
  • Altium Capital Management fully exited PepperLime Health Acquisition Corporation Class A Ordinary Share in Q1 2022, selling an estimated $7.2M.
  • Altium Capital Management's ten largest holdings make up 28% of its $299M portfolio in Q1 2022.
  • Altium Capital Management opened 33 new positions and closed 48 in Q1 2022.
  • Altium Capital Management's portfolio value fell 18% quarter-over-quarter to $299M.

Based on Altium Capital Management's 13F filing for Q1 2022, filed 16 May 2022.